Cardiovascular

InterVene Draws in Support from VC firms and Boston Sci

The South San Francisco-based company has raised $15 million in a series B round to get its catheter-based solution for deep vein reflux into clinical trials.

Published Study Supports MyoKardia’s Wrist-Worn Biosensor

The South San Francisco-based company has developed a wearable that has the potential to screen for obstructive hypertrophic cardiomyopathy.

12 FDA Panel Questions on Paclitaxel-Coated Devices

While an FDA advisory panel struggled with data discrepancies this week, panel members did attempt to answer these 12 questions for the agency.

Large Financing Round Breathes New Life into Acutus’ AcQMap

The Carlsbad, CA-based company raised $100 million from a Series D Equity round and $70 million from a credit facility.

Ra Goes the Distance with Dabra in New Clinical Study

The Carlsbad, CA-based company is conducting the RESULTS study, which will gather data for its Dabra Excimer Laser System for two years, post-treatment of peripheral artery disease.

Terumo ‘Tunes Up’ Orchestra BioMed with $30M Payment

The companies formed a noteworthy strategic partnership to support the development and commercialization of Orchestra’s drug-eluting balloon.

Boston Sci Initiates New Watchman FLX Study

The OPTION trial will compare the Watchman FLX device’s safety and effectiveness to that of anticoagulants for reducing stroke risk in atrial fibrillation patients.

10 of the Most Influential Companies in the Cardiovascular Space

The cardiovascular space has been among the most exciting in medtech in recent years. MD+DI has compiled a list of companies in the market that are having a profound impact.

Jury Orders J&J to Pay Woman $80M in Vaginal Mesh Case

The decision comes on the heels of FDA ordering Boston Scientific and Coloplast to stop selling vaginal mesh products.

Medtronic’s Redemption Arc for RDN Continues at EuroPCR

The Dublin-based company has been building up data through numerous trials to help support the recovery of its renal denervation program.

Gore Scores FDA Nod for More Precise TEVAR Solution

The company said its Gore Active Control System provides controlled, two-stage deployment, with primary deployment to an intermediate diameter and a secondary deployment to full diameter.

FDA Says Patient Selection is Key to Abiomed Impella RP Safety

FDA urged doctors on Tuesday to read and follow the revised labeling for Abiomed's Impella RP System, which includes a patient selection checklist to understand which patients may benefit most from treatment with the device.

Boston Sci’s Emblem Results Are ‘Untouched’ at HRS 2019

UNTOUCHED is global, prospective, non-randomized study evaluated data from 1,116 patients with a low left ventricular ejection fraction, the majority of whom (54%) had ischemic heart disease.

Varian Is in Bold New Territory with Acquisition

The Palo Alto, CA-based company is acquiring CyberHeart and will enter into the cardiac radioablation market.

HRS: Ear Clip Uses Neurostimulation to Effectively Reduce AFib Burden

The TREAT AF trial results were presented at the Heart Rhythm Society’s 40th Annual Scientific Sessions, and the device evaluated in the study was developed by Parasym.

Could Better Materials Lead to Better Outcomes with DCBs?

Researchers from the Boston University School of Medicine have examined these coatings of drug-coated balloons at microscopic levels in hopes of producing more efficient alternatives for treating arterial disease.

Qmed Search Form